InvestSMART

Resonance Health Limited (ASX: RHT) - Announcements

Current share price for RHT : $0.060 0.003 (5.26%)+

ASX company news and announcements for Resonance Health Limited (RHT) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Resonance Health Limited (RHT) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Resonance Health Limited (RHT), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Resonance Health Limited (RHT)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$29 RHT Update 6 Jun 2014 10:04AM $0.050 $0.060 risen by 20%
$29 RHT signs Non-Binding Heads of Agreement 3 Jun 2014 10:16AM $0.047 $0.060 risen by 27.66%
$29 Suspension - ASX Code RHTN (Deferred) 2 Jun 2014 2:32PM $0.052 $0.060 risen by 15.38%
$29 Trading Halt 30 May 2014 12:32PM $0.052 $0.060 risen by 15.38%
$29 HepaFat-Scan gains TGA Listing and CE Mark 29 May 2014 2:58PM $0.055 $0.060 risen by 9.09%
$29 Operational update and extension of Closing Date 19 May 2014 6:02PM $0.049 $0.060 risen by 22.45%
$29 Appendix 4C - quarterly 30 Apr 2014 6:03PM $0.051 $0.060 risen by 17.65%
$29 Cleansing Statement - Rights Issue Offer Document 22 Apr 2014 8:27AM $0.053 $0.060 risen by 13.21%
$29 Placement and entitlements offer to raise $5.1million 10 Apr 2014 9:29AM $0.053 $0.060 risen by 13.21%
$29 Trading Halt 7 Apr 2014 5:54PM $0.063 $0.060 fallen by 4.76%
$29 Half Yearly Report and Accounts 28 Feb 2014 8:25AM $0.071 $0.060 fallen by 15.49%
$29 Reponse to ASX Price and Volume Query 26 Feb 2014 5:06PM $0.076 $0.060 fallen by 21.05%
$29 Appendix 4C - quarterly 31 Jan 2014 12:11PM $0.077 $0.060 fallen by 22.08%
$29 Response to ASX Price and Volume Query 7 Jan 2014 5:51PM $0.089 $0.060 fallen by 32.58%
$29 FDA Clearance for HepaFat-Scan 20 Dec 2013 12:09PM $0.082 $0.060 fallen by 26.83%
$29 Response to ASX Price and Volume Query 2 Dec 2013 3:52PM $0.055 $0.060 risen by 9.09%
$29 Appendix 4C - quarterly Q1 September 2013 31 Oct 2013 6:04PM $0.014 $0.060 risen by 328.57%
$29 Appendix 4C - quarterly Q1 September 2013 31 Oct 2013 5:21PM $0.014 $0.060 risen by 328.57%
$29 Preliminary Final Report 30 Aug 2013 1:32PM $0.012 $0.060 risen by 400%
$29 Appendix 4C - quarterly 30 Jul 2013 10:16AM $0.013 $0.060 risen by 361.54%
$29 New FerriScan Contract-Phase II Clinical Trial 23 Jul 2013 12:15PM $0.014 $0.060 risen by 328.57%
$29 FerriScan Multicentre Validation Publication 8 Jul 2013 10:20AM $0.011 $0.060 risen by 445.45%
$29 Appendix 4C - quarterly 29 Apr 2013 5:55PM $0.015 $0.060 risen by 300%
$29 HepaFat Scan Update 8 Apr 2013 8:27AM $0.015 $0.060 risen by 300%
$29 FerriScan contracted for EU funded drug trial 3 Apr 2013 1:16PM $0.017 $0.060 risen by 252.94%

401 - 425 of 532 results

Page 17 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.